Ciclopirox: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Ciclopirox}} | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
Line 11: | Line 11: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
''' [[ | ''' [[Ciclopirox description|Description]]''' | ||
'''| [[ | '''| [[Ciclopirox clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[Ciclopirox microbiology|Microbiology]]''' | ||
'''| [[ | '''| [[Ciclopirox indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[Ciclopirox contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[Ciclopirox warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[Ciclopirox adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[Ciclopirox drug interactions|Drug Interactions]]''' | ||
'''| [[ | '''| [[Ciclopirox overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[Ciclopirox clinical studies|Clinical Studies]]''' | ||
'''| [[ | '''| [[Ciclopirox dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[Ciclopirox how supplied|How Supplied]]''' | ||
'''| [[ | '''| [[Ciclopirox labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== |
Revision as of 00:31, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
Category
Antifungal
US Brand Names
Ciclodan®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages